News that hedge-fund giant Citadel plans to buy KCG's market-making operations raises a lot of questions, says Ron Insana.» Read More
Trump accuses hedge funds of "Getting away with murder"
Regulators said they would move forward with a civil case against the hedge fund billionaire after prosecutors dropped insider trading charges.
Jim McCaughan, CEO, Principal Global Investors, says most hedge funds before the financial crisis did well in spite of themselves.
CNBC got a look at the rare collection of flora, fauna, exotic animals in a billionaire's garden, which includes real black swans.
Howard Marks, chairman of Oaktree Capital, shared his market views and investment strategies with CNBC on Friday.
Legendary short seller, founder of Kynikos Associates, shared his market views and ideas with CNBC on Thursday.
Hedge fund managers faced a tricky question this holiday season: how to thank employees but not offend disappointed clients.
Qualcomm won't separate its chipmaking and technology licensing businesses, concluding a six-month strategic review pushed by Jana Partners.
Embattled investment firm Third Avenue Management has ditched CEO David Barse, the company confirmed on Monday.
Third Avenue has ditched CEO David Barse, The Wall Street Journal reported on Sunday, amid turmoil stemming from bad junk bond bets.
Einhorn has been skeptical of the stock for years and took a bearish, or short, position on Keurig shares at an average cost of $102.
Sovereign wealth funds in the Gulf have been pulling money out of asset managers at the fastest rate on record, the Financial Times reports.
Moazzam Ifzal "Mark" Malik from Lahore, Pakistan, was convicted on all 28 counts he faced, including grand larceny and securities fraud.
Malaysia's anti-graft agency met with officials at Prime Minister Najib Razak's office over investigations into the 1MDB scandal.
The hedge fund mogul's fund has lost 20.6 percent this year as a bet on solar company SunEdison cratered in November.
Singapore sovereign fund GIC takes a long view on real-estate plays, eyeing emerging markets despite recent turmoil, its property chief said.
The activist hedge fund run by billionaire Nelson Peltz is ending quarterly redemptions by its new investors.
Michael Yee, BioTech Analyst, RBC Capital Markets, on why shares of Gilead are up 12 percent so far this year.
CNBC's Kate Kelly reports on some big bearish bets being made on crude oil.
Melvin Capital, a $1.5 billion fund that focuses primarily on consumer stocks, is up nearly 40 percent through the end of October.